-- Podcast to be Available Following Conference Call --
CAMBRIDGE, Mass.--(BUSINESS WIRE)--July 31, 2008--Alkermes, Inc. (NASDAQ: ALKS) will host a conference call at 4:30 p.m. EDT on Thursday, August 7, 2008 to discuss the company's financial results for its first quarter of fiscal 2009. Management will review the quarter and provide an update on the company.
The conference call will be webcast on the investor relations section of Alkermes' website at www.alkermes.com or may be accessed by dialing 1-866-793-1306 for domestic callers and 1-703-639-1308 for international callers. The conference call ID number is 1262420.
A replay of the conference call will be available from 7:30 p.m. EDT on Thursday, August 7, 2008 through 5 p.m. EDT on Thursday, August 14, 2008, and may be accessed by visiting Alkermes' website or by dialing 1-888-266-2081 for domestic callers and 1-703-925-2533 for international callers. The replay access code is 1262420. Alkermes is also providing a podcast MP3 file available for download on the Alkermes website, which will be available shortly following the conference call and will be available until Thursday, August 14, 2008.
About Alkermes
Alkermes, Inc., a biotechnology company committed to developing innovative medicines to improve patients' lives, manufactures RISPERDAL(R) CONSTA(R) for schizophrenia and developed and manufactures VIVITROL(R) for alcohol dependence. Alkermes' robust pipeline includes extended-release injectable, pulmonary and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, Alkermes has research and manufacturing facilities in Massachusetts and Ohio.
CONTACT: Alkermes, Inc.
Eva Stroynowski, 617-583-6823
Associate, Corporate Communications
SOURCE: Alkermes, Inc.